For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
AERVGLLEIGQEVHDVAVVVRAGGEVDSGTVETLAAALDSAVAAAAAHPTRTVVVDLDGITYFGSAGLNA LLTCREEGEGRGVVVRLVATTAEVTRPIEVTRLARILRPYPSVGEAVAAPEDPPEDPR*
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. gilvum PYR-GCK | Mflv_4424 | - | - | 100% (129) | anti-sigma-factor antagonist |
| M. gilvum PYR-GCK | Mflv_4938 | - | 9e-09 | 30.69% (101) | anti-sigma-factor antagonist |
| M. gilvum PYR-GCK | Mflv_2021 | - | 2e-08 | 35.85% (106) | anti-sigma-factor antagonist |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb1400c | - | 1e-08 | 32.08% (106) | hypothetical protein Mb1400c |
| M. tuberculosis H37Rv | Rv1365c | rsfA | 1e-08 | 32.08% (106) | anti-anti-sigma factor RSFA (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | - | - | - | - | - |
| M. marinum M | MMAR_0737 | - | 1e-25 | 50.83% (120) | anti sigma factor antagonist |
| M. avium 104 | MAV_5272 | - | 6e-10 | 33.04% (112) | anti-anti-sigma factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 1e-05 | 29.03% (93) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_1832 | - | 2e-08 | 30.84% (107) | ANTI-ANTI-SIGMA FACTOR RSFB (ANTI-SIGMA FACTOR ANTAGONIST) |
| M. ulcerans Agy99 | MUL_3602 | - | 2e-25 | 50.00% (120) | anti sigma factor antagonist |
| M. vanbaalenii PYR-1 | Mvan_1481 | - | 1e-09 | 31.68% (101) | anti-sigma-factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
MMAR_0737|M.marinum_M ----MTHSRAVKAMDLLAVEHEVRQDTVVVRAKGDVDSSTVEQLVVHLAA
MUL_3602|M.ulcerans_Agy99 -------------MDLLAVEHEVRQDTVVVRAKGDVDSSTVEQLVVHLAA
Mflv_4424|M.gilvum_PYR-GCK ---------MAERVGLLEIGQEVHDVAVVVRAGGEVDSGTVETLAAALDS
MAV_5272|M.avium_104 ---MGEQPGDLADPTPFEVGKHQVDQAVVLTVSGEVDMLSSPMLAEAVQT
MSMEG_6127|M.smegmatis_MC2_155 ---MTSQ-----DPANCTVEERRVGDITVVAVTGTVDMLTAPKLEDAIGS
TH_1832|M.thermoresistible__bu ------------------VEHR--DDSAVLRVQGVVDLATGDALQQAIDD
Mvan_1481|M.vanbaalenii_PYR-1 ---MDVSG--HGRSRGFSVSPDRQGAALVLRVTGDLDAMTAPTLVTHLDI
Mb1400c|M.bovis_AF2122/97 MNPTQAGSFTTPVSNALKATIQHHDSAVIIHARGEIDAANEHTWQDLVTK
Rv1365c|M.tuberculosis_H37Rv MNPTQAGSFTTPVSNALKATIQHHDSAVIIHARGEIDAANEHTWQDLVTK
:: . * :* . :
MMAR_0737|M.marinum_M AMQLAATHPARLVVIDLQPVTFFGSAGLNAVLECHEQGMAAGTSVRLVAD
MUL_3602|M.ulcerans_Agy99 AMQLAATHPARLVVIDLQPVTFFGSAGLNAVLECHEQGMAAGTSVRLVAD
Mflv_4424|M.gilvum_PYR-GCK AVAAAAAHPTRTVVVDLDGITYFGSAGLNALLTCREEGEGRGVVVRLVAT
MAV_5272|M.avium_104 ALAAKPA----ALIVDLSKVGFLASAGMTVLVTTQAELQPP-TKFAVVAD
MSMEG_6127|M.smegmatis_MC2_155 AAKSEPS----AVVVDLSAVDFLASAGMGVLVAAHGELAPA-VRLVVVAD
TH_1832|M.thermoresistible__bu LIATRPS----ALVVDLSAVDFLASVGLQILVATHERLSPS-ARFAVVAD
Mvan_1481|M.vanbaalenii_PYR-1 ALADAPP----VVVVDMTDVEFLSSAGISVLVETHRLAERADISLRVVAD
Mb1400c|M.bovis_AF2122/97 AAAATTAP--EPLVVNLNGLDFMGCCAVAVLAHKAERCRRRGVDVRLVSR
Rv1365c|M.tuberculosis_H37Rv AAAATTAP--EPLVVNLNGLDFMGCCAVAVLAHEAERCRRRGVDVRLVSR
.. ::::: : ::.. .: : . :*:
MMAR_0737|M.marinum_M HGQVLAPIQVTELDRIFEIYPTLAGALRPGKPGEHDLEDVERPR
MUL_3602|M.ulcerans_Agy99 HGQLLAPIQVTELDRIFEIYPTLAGALRPGKPGEHDLEDVERPR
Mflv_4424|M.gilvum_PYR-GCK TAEVTRPIEVTRLARILRPYPSVGEAVAAPE------DPPEDPR
MAV_5272|M.avium_104 GSATSRPIKLMGIDSVLSLYPSLNDALSALSGA-----------
MSMEG_6127|M.smegmatis_MC2_155 GPATSRPLKLVGIADVVDLFATLDEALSSLKT------------
TH_1832|M.thermoresistible__bu GPATSRPIQLTRLDEVIALYPTLDEALSGVRTGERAE-------
Mvan_1481|M.vanbaalenii_PYR-1 GPATSRPFRMMRLDEVIDLYPTLADAMGERQQGRPPT-------
Mb1400c|M.bovis_AF2122/97 DRAVARIIHACGYGDVLPVHPTTESALSAT--------------
Rv1365c|M.tuberculosis_H37Rv DRAVARIIHACGYGDVLPVHPTTESALSAT--------------
:. :. ..: *: